US2466420A
(en)
|
1947-11-26 |
1949-04-05 |
Eastman Kodak Co |
Ketene condensation products with aldehydes
|
US3226394A
(en)
|
1964-06-16 |
1965-12-28 |
Shulton Inc |
Pyridylethylated anthranilamides and derivatives thereof
|
CH504416A
(de)
|
1966-12-05 |
1971-03-15 |
Ciba Geigy Ag |
Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen
|
US4551540A
(en)
|
1983-01-17 |
1985-11-05 |
Borg-Warner Chemicals, Inc. |
Substituted 2,5-dimethylpyrroles
|
US5190541A
(en)
|
1990-10-17 |
1993-03-02 |
Boston Scientific Corporation |
Surgical instrument and method
|
ES2193143T3
(es)
|
1992-03-05 |
2003-11-01 |
Univ Texas |
Uso de inmunoconjugados para la diagnosis y/o terapia de tumores vascularizaos.
|
US5474765A
(en)
|
1992-03-23 |
1995-12-12 |
Ut Sw Medical Ctr At Dallas |
Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
|
US5686472A
(en)
|
1992-10-29 |
1997-11-11 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5593992A
(en)
|
1993-07-16 |
1997-01-14 |
Smithkline Beecham Corporation |
Compounds
|
WO1996011932A1
(en)
|
1994-10-14 |
1996-04-25 |
Smithkline Beecham Plc |
2-(imidazol-4-yl)carbapeneme derivatives, intermediates thereof and use as antibacterials
|
KR19990007865A
(ko)
|
1995-04-19 |
1999-01-25 |
스피겔알렌제이 |
약물 방출용 피복 스텐트
|
US6117432A
(en)
|
1995-04-20 |
2000-09-12 |
Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) |
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
|
TW349948B
(en)
|
1995-10-31 |
1999-01-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 2-quinolone derivatives
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
IL123568A
(en)
|
1995-12-08 |
2001-08-08 |
Janssen Pharmaceutica Nv |
History (Imidazole - 5Il) Methyl-2-quinolinone inhibitors of Prenzyl transferase, their preparation, pharmaceutical preparations containing them and their preparation and drugs containing them
|
US5874442A
(en)
|
1995-12-22 |
1999-02-23 |
Schering-Plough Corporation |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US5702390A
(en)
|
1996-03-12 |
1997-12-30 |
Ethicon Endo-Surgery, Inc. |
Bioplar cutting and coagulation instrument
|
JPH11514676A
(ja)
|
1996-08-09 |
1999-12-14 |
メルク エンド カンパニー インコーポレーテッド |
立体選択的脱酸素化反応
|
ATE252104T1
(de)
|
1996-12-20 |
2003-11-15 |
Tovarischestvo S Ogranichennoi |
Verfahren und gerät zur herstellung von 1ss, 10ss-epoxy-13-dimethylamino-guaia-3(4)-en-6,12- lid- hydrochlorid
|
UA59384C2
(uk)
|
1996-12-20 |
2003-09-15 |
Пфайзер, Інк. |
Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
|
TW591030B
(en)
|
1997-03-10 |
2004-06-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
|
HUP0001122A3
(en)
|
1997-04-25 |
2002-03-28 |
Janssen Pharmaceutica Nv |
Farnesyltransferase inhibiting quinazolinones
|
TW491872B
(en)
|
1997-05-27 |
2002-06-21 |
Ciba Sc Holding Ag |
Block oligomers containing l-hydrocarbyloxy-2,2,6,6-tetramethyl-4- piperidyl groups as stabilizers for lower polyolefin
|
US6100254A
(en)
|
1997-10-10 |
2000-08-08 |
Board Of Regents, The University Of Texas System |
Inhibitors of protein tyrosine kinases
|
PL192621B1
(pl)
|
1998-03-05 |
2006-11-30 |
Formula One Administration Ltd |
Sposób i system transmisji danych, zwłaszcza sygnału wizyjnego
|
US6303654B1
(en)
|
1998-03-12 |
2001-10-16 |
Wisconsin Alumni Research Foundation |
Acyclic monoterpenoid derivatives
|
AU5086499A
(en)
|
1998-07-01 |
2000-01-24 |
Merck & Co., Inc. |
Process for making farnesyl-protein transferase inhibitors
|
CA2336848A1
(en)
|
1998-07-10 |
2000-01-20 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
EP1107962B1
(en)
|
1998-08-27 |
2005-02-23 |
Pfizer Products Inc. |
Quinolin-2-one derivatives useful as anticancer agents
|
EE200100118A
(et)
|
1998-08-27 |
2002-06-17 |
Pfizer Products Inc. |
Vähivastaste vahenditena kasulikud alkünüül-asendatud kinoliin-2-ooni derivaadid
|
GB9824579D0
(en)
|
1998-11-10 |
1999-01-06 |
Novartis Ag |
Organic compounds
|
SK286072B6
(sk)
|
1998-12-23 |
2008-02-05 |
Janssen Pharmaceutica N. V. |
1,2-anelované chinolínové deriváty, spôsob ich prípravy, medziprodukty, farmaceutický prostriedok aich použitie
|
DE1140938T1
(de)
|
1999-01-11 |
2003-01-09 |
Princeton University Princeton |
Kinase-inhibitoren mit hoher affinität zur ziel detektion und ihre verwendung
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
EP1169038B9
(en)
|
1999-04-15 |
2013-07-10 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
ATE269357T1
(de)
|
1999-04-28 |
2004-07-15 |
Univ Texas |
Zusammensetzungen und verfahren zur krebsbehandlung durch die selektive hemmung von vegf
|
US6346625B1
(en)
|
1999-06-23 |
2002-02-12 |
Astrazeneca Ab |
Protein kinase inhibitors
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
AU2457201A
(en)
|
1999-12-28 |
2001-07-09 |
Bristol-Myers Squibb Company |
Cytokine, especially tnf-alpha, inhibitors
|
FR2803592A1
(fr)
|
2000-01-06 |
2001-07-13 |
Aventis Cropscience Sa |
Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant.
|
US6558385B1
(en)
|
2000-09-22 |
2003-05-06 |
Tissuelink Medical, Inc. |
Fluid-assisted medical device
|
US6692491B1
(en)
|
2000-03-24 |
2004-02-17 |
Scimed Life Systems, Inc. |
Surgical methods and apparatus for positioning a diagnostic or therapeutic element around one or more pulmonary veins or other body structures
|
US6776796B2
(en)
|
2000-05-12 |
2004-08-17 |
Cordis Corportation |
Antiinflammatory drug and delivery device
|
WO2002032861A2
(en)
|
2000-10-17 |
2002-04-25 |
Merck & Co., Inc. |
Orally active salts with tyrosine kinase activity
|
US6958243B2
(en)
*
|
2000-12-14 |
2005-10-25 |
Biotage Ab |
Organic reactions with CO generating materials
|
US7105682B2
(en)
|
2001-01-12 |
2006-09-12 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
AR035885A1
(es)
|
2001-05-14 |
2004-07-21 |
Novartis Ag |
Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
|
WO2003024931A1
(en)
|
2001-09-14 |
2003-03-27 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
US7101884B2
(en)
|
2001-09-14 |
2006-09-05 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
TWI259081B
(en)
|
2001-10-26 |
2006-08-01 |
Sugen Inc |
Treatment of acute myeloid leukemia with indolinone compounds
|
EP1441737B1
(en)
|
2001-10-30 |
2006-08-09 |
Novartis AG |
Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
|
RU2316554C2
(ru)
|
2001-12-27 |
2008-02-10 |
Тереванс, Инк. |
Производные индолина, используемые как ингибиторы протеинкиназы
|
CA2486183C
(en)
|
2002-05-23 |
2012-01-10 |
Cytopia Pty Ltd. |
Protein kinase inhibitors
|
AR037647A1
(es)
|
2002-05-29 |
2004-12-01 |
Novartis Ag |
Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
BR0313397A
(pt)
|
2002-08-14 |
2005-06-28 |
Vertex Pharmaceuticals Incorpo |
Inibidores de proteina cinase e usos destes
|
WO2004018419A2
(en)
|
2002-08-23 |
2004-03-04 |
Chiron Corporation |
Benzimidazole quinolinones and uses thereof
|
WO2004022525A1
(en)
|
2002-09-05 |
2004-03-18 |
Neurosearch A/S |
Amide derivatives and their use as chloride channel blockers
|
KR20110050745A
(ko)
|
2002-10-03 |
2011-05-16 |
탈자진 인코포레이티드 |
혈관항상성 유지제 및 그의 사용 방법
|
JPWO2004039782A1
(ja)
|
2002-10-29 |
2006-03-02 |
麒麟麦酒株式会社 |
Flt3自己リン酸化を阻害するキノリン誘導体およびキナゾリン誘導体並びにそれらを含有する医薬組成物
|
SG148864A1
(en)
|
2002-11-13 |
2009-01-29 |
Chiron Corp |
Methods of treating cancer and related methods
|
AR042052A1
(es)
|
2002-11-15 |
2005-06-08 |
Vertex Pharma |
Diaminotriazoles utiles como inhibidores de proteinquinasas
|
EP1581526B1
(en)
|
2002-12-18 |
2009-03-11 |
Vertex Pharmaceuticals Incorporated |
Benzisoxazole derivatives useful as inhibitors of protein kinases
|
BRPI0409136A
(pt)
|
2003-04-09 |
2006-04-25 |
Japan Tobacco Inc |
composto heteroaromático pentacìclico e uso medicinal do mesmo
|
US7429603B2
(en)
|
2003-04-25 |
2008-09-30 |
3-Dimensional Pharmaceuticals, Inc. |
C-fms kinase inhibitors
|
US20050113566A1
(en)
|
2003-04-25 |
2005-05-26 |
Player Mark R. |
Inhibitors of C-FMS kinase
|
US7790724B2
(en)
|
2003-04-25 |
2010-09-07 |
Janssen Pharmaceutica N.V. |
c-fms kinase inhibitors
|
US7427683B2
(en)
*
|
2003-04-25 |
2008-09-23 |
Ortho-Mcneil Pharmaceutical, Inc. |
c-fms kinase inhibitors
|
MXPA06001094A
(es)
|
2003-07-28 |
2006-04-11 |
Smithkline Beecham Corp |
Compuestos quimicos.
|
PL1684750T3
(pl)
|
2003-10-23 |
2010-10-29 |
Ab Science |
2-Aminoarylooksazole jako inhibitory kinazy tyrozynowej
|
GB0326601D0
(en)
|
2003-11-14 |
2003-12-17 |
Novartis Ag |
Organic compounds
|
WO2005073225A1
(en)
|
2004-01-30 |
2005-08-11 |
Ab Science |
2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
|
US7645755B2
(en)
|
2004-10-22 |
2010-01-12 |
Janssen Pharmaceutical N.V. |
Inhibitors of c-fms kinase
|
JP5008569B2
(ja)
*
|
2004-10-22 |
2012-08-22 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
C−fmsキナーゼのインヒビターとしての芳香族アミド
|
US7662837B2
(en)
|
2004-10-22 |
2010-02-16 |
Janssen Pharmaceutica N.V. |
Inhibitors of c-fms kinase
|
PT1807077T
(pt)
|
2004-10-22 |
2017-01-06 |
Janssen Pharmaceutica Nv |
Inibidores de quinase c-fms
|
US20060281771A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators
|
US20060281700A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
|
US20060281755A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
|
US20060281788A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
|
US20060281769A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators
|
CN101340909B
(zh)
|
2005-10-18 |
2012-01-11 |
詹森药业有限公司 |
抑制flt3激酶的方法
|
DK2021335T3
(da)
|
2006-04-20 |
2011-09-05 |
Janssen Pharmaceutica Nv |
Heterocykliske forbindelser som C-FMS-kinasehæmmere
|
EP2687516A1
(en)
|
2006-04-20 |
2014-01-22 |
Janssen Pharmaceutica N.V. |
Inhibitors of C-FMS Kinase
|
US8697716B2
(en)
|
2006-04-20 |
2014-04-15 |
Janssen Pharmaceutica Nv |
Method of inhibiting C-KIT kinase
|
PE20080074A1
(es)
|
2006-04-20 |
2008-02-11 |
Janssen Pharmaceutica Nv |
Derivados de amida como agentes inhibidores de la quinasa c-fms
|
EP2134713A2
(en)
*
|
2006-12-20 |
2009-12-23 |
Schering Corporation |
Novel jnk inhibitors
|
WO2008138184A1
(fr)
*
|
2007-05-14 |
2008-11-20 |
Shanghai Hengrui Pharmaceutical Co.Ltd. |
Dérivés de pyrrolo-azacycles, leur procédé de fabrication et leur utilisation en tant qu'inhibiteurs de protéine kinases
|
JO3240B1
(ar)
|
2007-10-17 |
2018-03-08 |
Janssen Pharmaceutica Nv |
c-fms مثبطات كيناز
|
AU2008318656A1
(en)
|
2007-10-31 |
2009-05-07 |
Janssen Pharmaceutica N.V. |
Biomarker for assessing response to FMS treatment
|
CA2748274A1
(en)
*
|
2008-12-30 |
2010-07-08 |
Millennium Pharmaceuticals, Inc. |
Heteroaryl compounds useful as raf kinase inhibitors
|
JP2011026305A
(ja)
*
|
2009-06-24 |
2011-02-10 |
Daiichi Sankyo Co Ltd |
イミダゾールカルボニル化合物を含有する医薬組成物
|
SI2483278T1
(sl)
*
|
2009-09-28 |
2014-03-31 |
F. Hoffmann-La Roche Ag |
Inhibitorske spojine benzoksazepina pi3k in njihova uporaba pri zdravljenju raka
|
WO2011090935A1
(en)
*
|
2010-01-19 |
2011-07-28 |
Merck Sharp & Dohme Corp. |
PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
|
IN2015DN00659A
(pt)
*
|
2012-08-07 |
2015-06-26 |
Janssen Pharmaceutica Nv |
|